Health Day - ONLINE EDITION
Posted: 09/19/2013 6:00 AM | Comments: 0
WEDNESDAY, Sept. 18 (HealthDay News) -- In women with early breast cancer, three weeks of high-dose radiation is as effective as the current standard -- five weeks of lower-dose treatment, British researchers say.
A short course of radiation given in larger doses -- an approach called hypofractionated radiation -- is safe and effective and causes less damage to healthy surrounding tissue, according to the 10-year results of two British trials. The short course is also more convenient and less expensive.
"For most indications, a three-week course of postoperative radiotherapy can be recommended as standard of care for women with early breast cancer following breast conservation surgery or mastectomy," said study researcher Dr. John Yarnold, a professor of clinical oncology at the Institute of Cancer Research in London.
"Three weeks of treatment is gentler on the healthy tissues without loss of anti-cancer effect, so it represents an improvement for women with early breast cancer," he added.
The report, published Sept. 19 in The Lancet Oncology, may not change current practice immediately, however, said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City.
The short course is "a great alternative and may eventually replace long-term radiation," Bernik said. But she thinks studies conducted in the United States are needed to convince U.S. oncologists of the benefits.
"They want a little experience with it before they start doing it automatically," she added. "But you will probably see it more and more."
Already, some places in the United States use the three-week course, she said, adding, "we have been waiting for the results of a long-term study."
In this case, between 1999 and 2002, researchers conducted two trials -- U.K. Standardization of Breast Radiotherapy, known as START A and B. The trials tested different radiation doses and timing schedules among 4,451 women treated at 35 centers across the United Kingdom.
START A compared the international standard -- a total of 50 Gy given in 25 small doses over five weeks -- with two other schedules: 41.6 Gy and 39 Gy, each given in 13 treatments over five weeks.
START B compared the international standard with 40 Gy given in 15 doses of 2.67 Gy over three weeks.
Over 10 years of follow-up, the results of START A were similar regardless of the dose of radiation. In all three cases, the cancer relapse rate was about the same, ranging from 6.3 percent to 8.8 percent. Damage to surrounding tissue was also similar regardless of the dose of radiation, the researchers noted.
In START B, similar results were also seen after 10 years, with relapses ranging from 5.5 percent to 4.3 percent. Damage to surrounding tissue, however, was significantly less than in START A, the researchers found.
The outcomes of the two trials were independent of age, tumor grade, stage, chemotherapy use, or use of tumor bed boost -- additional radiation therapy, the study authors pointed out.
For more information on breast cancer, visit the American Cancer Society.
Have you found an error, or know of something we’ve missed in one of our stories? Please use the form below and let us know.
Having problems with the form?Contact Us Directly
Get your butt in gear: Strong glutes mean healthy back, hip and knees
Training basket: Chantal Larocque
Health region faxes patients' reports to wrong place
Spaceflight Might Weaken Astronauts' Immune Systems
Take Steps to Control Bunions
Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans
Faced With Prostate Cancer, It Helps to Know the Enemy
Winnipeg lab created, tested Ebola drug ZMapp
Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says
Scientists Find Differences in Brains of Those With Dyslexia
Encouraging Your Baby's Babbling May Speed Language Development
Study Counters Critics of Plainer Cigarette Packaging
European MRSA Originated in Sub-Saharan Africa, Study Finds
'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds
Health Highlights: Aug. 29, 2014
Health Tip: Exercise While Watching Television
Health Tip: Teach Your Child to Read Food Labels
OK, so we have germs. But they're our unique germs
Life of a pot-store owner: Guards and cash
Take the time to pack kids a healthier lunch
L'Alpette brand sheep cheese recalled
Could Too Much Salt Harm MS Patients?
Saskatchewan to cover cystic fibrosis drug
Parents' Fights May Strain Bonds With Their Kids
Most U.S. Babies Get Their Vaccines: CDC
Less Sleep in Teen Years Tied to More Pounds at 21
Shades of Pigpen: We travel with our own germs
Scientists dig into Ebola's deadly DNA for clues
Electrical Pulses to Scalp May Boost Memory: Study
Gene Research Yields Insights Into Ebola Virus
Your Family's Germs May Move With You
Donated Livers Not Harmed by Travel Distances, Study Finds
Ebola Outbreak Could Infect 20,000 People, U.N. Says
Young Driver's Gender May Play Role in Timing, Type of Crash
Health Highlights: Aug. 28, 2014
US to begin safety testing Ebola vaccine next week
Concussion Recovery Can Reverse After Return to Activity, Study Shows
Eye Pigment May Help Vision in Hazy Conditions
California Trees Harbor Fungus Deadly to People With HIV
Health Tip: Recognizing Hay Fever